# Novartis AG: Form 6-K, filed Nov 28, 2023

- Company: [Novartis AG](/companies/nvs.md) (CIK 1114448)
- Form: 6-K
- Filed: 2023-11-28
- Accepted by EDGAR: Nov 28, 2023, 06:10 ET
- Period: 2023-11-28
- Accession: 0001171843-23-007295
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1114448/000117184323007295/f6k_112823.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1114448/000117184323007295/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1114448/000117184323007295/f6k_112823.htm

Filed Nov 28, 2023.
Source: SEC EDGAR, the filing index for accession 0001171843-23-007295. Last ingested by Listed: Nov 10, 2026, 04:31 ET. No prices; not investment advice.